Zurueck zur Suche

Reporte zur Charge UJ785AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VA 2 FL 2 WA 2 MI 2 PA 1 NJ 1 CT 1 CO 1

VAERS 2677503

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

mild
Staat
VA
Alter
0,3
Geschlecht
M
Eingang
29.08.2023
Impfdatum
14.08.2023
Beginn
14.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Faeces discoloured Rectal tenesmus

Symptomtext

Several weeks of diarrhea, foul-smelling, green and liquid stool with tenesmus, per Mother. No fever or other symptoms. Feeding well and has good urine output. Diarrhea is lasting longer than the 1 week that is expected. First dose of rotavirus received at 2 months of age, patient had diarrhea lasting almost 8 weeks (mother stated diarrhea lasted from his 2 month well check to his 4 month well check)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
Well at time of vaccination. Was previously having diarrhea lasting longer than 5 weeks suspected from Rotavirus vaccination at 2 months old.
Vorgeschichte
None
Andere Medikamente
Vitamin D infant drops
Allergien
possible allergy to cow's milk protein
Vorherige Impfungen
Diarrhea lasting almost 8 weeks from RotaTeq given on 06/12/2023 at 2 months of age

VAERS 2650433

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

mild
Staat
PA
Alter
0,5
Geschlecht
F
Eingang
28.06.2023
Impfdatum
27.06.2023
Beginn
27.06.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature increased Feeling abnormal Injection site induration Injection site warmth Insomnia

Symptomtext

Miserable, Temp 100.5, spitting up, insomnia, injection sites on left leg are hard and warm to the touch.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site induration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
GERD
Andere Medikamente
Famotidine, Ketoconazole
Allergien
Cow's Milk Protein
Vorherige Impfungen
Patient had identical reaction following 2 mon vaccines 02/21/2023 (pentacel, Prevnar13, Engerix, and Rotateq) and 4 mon vaccine

VAERS 2697540

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ785AA

gering
Staat
VA
Alter
0,2
Geschlecht
M
Eingang
18.10.2023
Impfdatum
12.10.2023
Beginn
12.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

consumer was given an expired dose of pentacel with no reported adverse event; Initial information received on 12-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 months old male patient who was given an expired dose of Diphtheria/Tetanus/5 Hybrid AC Pertussis/ IPV(VERO)/HIB(PRP/T) Vaccine [Pentacel (VERO)] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation. On 12-Oct-2023, the patient received a, expired 0.5 ml dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/ IPV(VERO)/HIB(PRP/T) Vaccine (lot UJ785AA, Expiry date: 09-Oct-2023 with unknown strength) via intramuscular route in the left thigh as immunization with no reported adverse event (expired product administered) (Latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR 13; ROTATEQ
Allergien
-
Vorherige Impfungen
-

VAERS 2697539

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ785AA

gering
Staat
FL
Alter
0,3
Geschlecht
F
Eingang
18.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patients were administered with an expired pentacel with no reported adverse event; Initial information received on 12-Oct-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 3 months old female patient where patients were administered with an expired diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine [Pentacel (vero)] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine conj 7v (crm197) (prevnar) and rotavirus vaccine live reassort oral 5v (rotateq) for Immunisation. On 10-Oct-2023, the patient received 0.5 ml (TOTAL) dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine Suspension for injection (lot- UJ785AA and expiration date- 09-Oct-2023) via intramuscular route in the left thigh (strength: not provided) for Immunisation (expired product administered) (latency- same day). Action taken- not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR; ROTATEQ
Allergien
-
Vorherige Impfungen
-

VAERS 2697537

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ785AA

gering
Staat
FL
Alter
0,2
Geschlecht
M
Eingang
18.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patients were administered with an expired pentacel with no reported adverse event; Initial information received on 12-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 months old male patient who were administered with an expired Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine [Pentacel (Vero)] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Immunisation; and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation. On 10-Oct-2023, the patient received a 0.5 ml dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine Suspension for injection (lot UJ785AA, expiry date: 09-Oct-2023 with unknown strength) via intramuscular route in the left thigh as prophylactic vaccination. On 10-Oct-2023 the patient was administered with an expired /Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine with no reported adverse event (expired product administered). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR; ROTATEQ
Allergien
-
Vorherige Impfungen
-

VAERS 2677501

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

gering
Staat
NJ
Alter
0,5
Geschlecht
F
Eingang
29.08.2023
Impfdatum
02.05.2023
Beginn
02.05.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

Vaccine was administered after the BUD. Parent has not reported any adverse reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
nnone
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2663167

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ785AA

gering
Staat
CT
Alter
0,3
Geschlecht
M
Eingang
31.07.2023
Impfdatum
19.07.2023
Beginn
19.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product preparation error Single component of a two-component product administered

Symptomtext

pentacel was not mixed before administration with no reported adverse event; patient was administered with just the liquid portion of the Pentacel without the Hib component with no reported adverse event; Initial information received on 24-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 month old male patient who was administered with just the liquid portion of the diphtheria/tetanus/5 Hybrid AC Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] without the hib component with no reported adverse event and was not mixed before administration. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal Vaccine Conj 13v (Crm197) (Prevnar 13), Rotavirus Vaccine Live Reassort Oral 5v (Rotateq) And Diphtheria Vaccine Toxoid, Hepatitis B Vaccine Rhbsag (Yeast), Hib Vaccine Conj (Menigococcal Protein), Pertussis Vaccine Acellular 5-Component, Polio Vaccine Inact 3v (Vero), Tetanus Vaccine Toxoid (Vaxelis) for Prophylactic vaccination. On 19-Jul-2023, the patient received a Dose 2 at a dose of 0.5 ml of suspect /tetanus/5 Hybrid AC Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine Suspension for injection (expiry date: 19-Oct-2023; lot UJ785AA) via intramuscular route in the right thigh for immunization and administered with just the liquid portion of the pentacel without the hib component with no reported adverse event (single component of a two-component product administered) (latency: same day). On an unknown date the pentacel was not mixed before administration with no reported adverse event (product preparation error) (latency: same day). It was reported "she called in together with the doctor to report that they have a patient who was administered with just the liquid portion of the PENTACEL; they have the patient back today to administer the Hib component and they ask which diluent is appropriate to prepare the dose; provided information to the practice manager and the doctor." Action taken: not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR 13; ROTATEQ; VAXELIS
Allergien
-
Vorherige Impfungen
-

VAERS 2636804

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

gering
Staat
CO
Alter
0,4
Geschlecht
M
Eingang
25.05.2023
Impfdatum
12.05.2023
Beginn
12.05.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered

Symptomtext

Pt was administered only the DTaP-IPV component of Pentacel (HIB was not mixed prior to administering).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2634932

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

gering
Staat
WA
Alter
0,5
Geschlecht
M
Eingang
22.05.2023
Impfdatum
19.05.2023
Beginn
19.05.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Administered a Pfizer vaccine from a vile opened on 5/18/23 at the appointment on 5/19/23. Appointment was at 10am but discovery of the error was not until 4pm. Discussed with a fellow RN in clinic who relayed the situation to our nurse manager. Nurse manager contacted me today (5/22/23) to advise me on how to proceed forward.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Was being assessed for possible peanut allergy concerns at time of the appointment
Vorgeschichte
None
Andere Medikamente
Vitamin D
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2634150

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

gering
Staat
MI
Alter
0,5
Geschlecht
F
Eingang
19.05.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Discontinued product administered

Symptomtext

Patient received monovalent Moderna vaccine instead of newly approved bivalent Moderna

Weitere VAERSDATA-Felder
Praegender Schweregrund
Discontinued product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Congenital hypothyroidism
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2634145

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

gering
Staat
MI
Alter
0,5
Geschlecht
F
Eingang
19.05.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Discontinued product administered

Symptomtext

Patient received monovalent Moderna instead of newly approved bivalent Moderna vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Discontinued product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Hydronephrosis
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2623353

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ785AA

gering
Staat
WA
Alter
0,5
Geschlecht
M
Eingang
28.04.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Patient doing well per mom. Dr. reviewed all information with mother via phone and is schedule to come back for a follow up within the week.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
acetaminophen (TYLENOL CHILDRENS) 160 MG/5ML Suspension sodium fluoride (LURIDE, PEDIAFLOX 1.1 MG/ML) 1.1 (0.5 F) MG/ML Solution Cholecalciferol (VITAMIN D3) 10 MCG/ML Liquid
Allergien
nkda
Vorherige Impfungen
-